Protege RX Carotid Stent System; Protege GPS Self-Expanding Peripheral Stent System
Medtronic Vascular, Inc. · Decision date Feb 11, 2026
What did the FDA decide?
FDA records P060001/S056 as a supplement to PMA P060001, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 11, 2026.
FDA approval order statement
a new fixture used in the stent microblasting process
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 11, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P060001/S056
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Vascular, Inc.
- Product code
- NIM
- Decision code
- OK30
- Decision date
- Feb 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stent, carotid.
- Applicant
- Medtronic Vascular, Inc.
- Product code
- NIM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P060001. Subsequent supplements may change the device or its indications.
FDA decision timeline
P060001 · Original PMA
PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS
P060001/S049 · Related supplement
Protégé RX Carotid Stent System
P060001/S050 · Related supplement
Protege RX Carotid Stent System; Protege GPS Self-Expanding Peripheral Stent System
P060001/S051 · Related supplement
Protege RX Carotid Stent System
P060001/S052 · Related supplement
Protégé GPS self-expanding Peripheral Stent System
P060001/S053 · Related supplement
Protégé GPS Self-expanding Peripheral Stent System
P060001/S054 · Related supplement
Protégé RX Carotid Stent System
P060001/S056 received
Application receipt date recorded by FDA.
P060001/S056 · FDA decision
30-Day Notice
P060001/S055 · Related supplement
Protege RX Carotid Stent System; Protege GPS Self-Expanding Peripheral Stent System
P060001/S057 · Related supplement
Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Carotid Stent System
P060001/S058 · Related supplement
Protege GPS Self-expanding Peripheral Stent System
P060001/S059 · Related supplement
Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Self-Expanding Carotid Stent System
P060001/S060 · Related supplement
PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS
Timeline entries are records held by MedtechLedger for P060001. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060001
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Vascular, Inc. | PMA approval | Jan 24, 2007 | FDA | |
Protégé RX Carotid Stent SystemP060001/S049 | Medtronic Vascular, Inc. | PMA supplement | Jul 17, 2025 | FDA |
| Medtronic Vascular, Inc. | PMA supplement | Jul 25, 2025 | FDA | |
Protege RX Carotid Stent SystemP060001/S051 | Medtronic Vascular, Inc. | PMA supplement | Aug 13, 2025 | FDA |
| Medtronic Vascular, Inc. | PMA supplement | Nov 7, 2025 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Dec 16, 2025 | FDA | |
Protégé RX Carotid Stent SystemP060001/S054 | Medtronic Vascular, Inc. | PMA supplement | Jan 23, 2026 | FDA |
| Medtronic Vascular, Inc. | PMA supplement | Feb 20, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Mar 23, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Jul 10, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMSP060001/S060 | Medtronic Vascular, Inc. | PMA supplement | Nov 5, 2026 | FDA |
Explore the linked device profile
Other records with product code NIM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Contego Medical, Inc. | PMA supplement | Nov 4, 2026 | FDA | |
| Contego Medical, Inc. | PMA supplement | Jul 29, 2026 | FDA | |
Roadsaver/CASPER Carotid Stent SystemP210030/S002 | Microvention, Inc. | PMA supplement | Jul 7, 2026 | FDA |
PRECISE PRO RX Nitinol Stent SystemP030047/S055 | Cordis US Corporation | PMA supplement | Jun 5, 2026 | FDA |
| Contego Medical, Inc. | PMA supplement | May 27, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Vascular, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 3033 Campus Dr., Plymouth, MN, 55441
Sources and methodology
- Original FDA record: P060001/S056
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records







